Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients

NCT02205164 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy Induced Nausea and Vomiting

Interventions

DRUG: Palonosetron + Aprepitant
DRUG: Palonosetron

Sponsor

Associazione Salentina Angela Serra